Abstract
Asthma is a common diagnosis for pediatric patients, and something frequently managed in the primary care setting. Due to the multitude of factors that affect asthma, obtaining good control of the disease can be difficult. Managing triggers, medications, and adherence are key to maintaining good asthma control and quality of life. The National Heart, Lung, and Blood Advisory Council has released new guidelines and recommendations to help assist in the management of asthma. The expert panel addressed several key areas and made recommendations based on the available data. Areas addressed were the use of intermittent inhaled corticosteroids, the use of long-acting muscarinic antagonist, allergen mitigation, fractional exhaled nitric oxide testing for asthma diagnosis and management, and immune modulation for asthma control. This article summarizes the key recommendations and changes to the guideline. [Pediatr Ann. 2022;51(4):e132-e135.].
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
